Biocryst Pharmaceuticals (BCRX) Return on Capital Employed [ROCE] (2011 - 2026)
Biocryst Pharmaceuticals (BCRX) recorded Return on Capital Employed [ROCE] of -103.49% in Q2 2026, down 122.08 percentage points from 18.60% a year earlier but up 26.29 percentage points from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, Biocryst Pharmaceuticals reported Return on Capital Employed [ROCE] of 111.35%, up 112.09 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has increased for six straight years, with a five-year change of +228.37 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at -0.74% in FY2024 (+26.30 pp), -27.04% in FY2023 (+4.98 pp), -32.02% in FY2022 (+17.66 pp) and -49.68% in FY2021 (+67.33 pp).
- Quarterly Return on Capital Employed [ROCE] has ranged from -129.78% in Q1 2026 to 119.97% in Q4 2025 over the past five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] rose in six of the last eight quarters, with an average year-over-year change of +1.28 percentage points.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 120.74 percentage points in Q4 2025, against a drop of 139.39 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -129.78% (Q1 2026), 119.97% (Q4 2025) and 29.09% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Biocryst Pharmaceuticals | 2.09 Bn | 1.01 Bn | 214.41 Mn | -103.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -103.49% |
| Mar 31, 2026 | -129.78% |
| Dec 31, 2025 | 119.97% |
| Sep 30, 2025 | 29.09% |
| Jun 30, 2025 | 18.60% |
| Mar 31, 2025 | 9.60% |
| Dec 31, 2024 | -0.77% |
| Sep 30, 2024 | -12.40% |
| Jun 30, 2024 | -17.68% |
| Mar 31, 2024 | -24.10% |
| Dec 31, 2023 | -28.03% |
| Sep 30, 2023 | -24.64% |
| Jun 30, 2023 | -26.48% |
| Mar 31, 2023 | -28.53% |
| Dec 31, 2022 | -33.08% |
| Sep 30, 2022 | -34.07% |
| Jun 30, 2022 | -42.82% |
| Mar 31, 2022 | -36.97% |
| Dec 31, 2021 | -54.98% |
| Sep 30, 2021 | -129.03% |
API Access
Biocryst Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();